Medical Information
Writing Services

Development of high-quality standard and custom medical response content to support consistent, accurate, and compliant communication with healthcare professionals, patients, or the general public

ProPharma Medical Information Writing

Timely, accurate, and scientifically balanced responses to medical inquiries are a core function of medical information teams. As product data expands and inquiry complexity increases, organizations often need additional support to develop and maintain clear, consistent responses that comply with current regulations for any given country.

ProPharma's Medical Information Writing team focuses on developing standard and custom medical response documents, helping ensure that responses provided to healthcare professionals are evidence-based, well-structured, and aligned with internal standards.

Our support spans initial content development through ongoing updates, with an emphasis on usability and consistency across responses.

Hands typing on laptop

Our Medical Information Writing Services

We provide focused support for the development and maintenance of medical information response content that is tailored to the intended audience.

Core Capabilities

  • Standard Response Documents (SRDs)

    Authoring, revision, and lifecycle maintenance of SRDs used to address common inquiries

  • Custom Medical Information Responses

    Development of tailored, literature-based reactive responses to specific or complex healthcare professional inquiries

  • Frequently Asked Questions (FAQ)

    We will work with you to determine the best approach for FAQ development

  • Content Updates and Maintenance

    Ongoing review and revision of existing materials to reflect new data, labeling updates, or evolving scientific understanding

  • Literature Searches and/or Analysis

    Searching medical literature using agreed databases, reference retrieval, and analysis of relevant results

  • Style Guide and Template Creation and/or Refinement

    Creation or refinement of style guides and/or templates to ensure consistent responses both now and for the future

  • Response Library Support

    Organization and expansion of content libraries to improve accessibility and reuse of approved responses

Working with ProPharma

Document search icon

Focused Medical Information Expertise

Our team specializes in medical information response writing, with decades of combined experience developing both standard and custom content for day-to-day...

Read More

Focused Medical Information Expertise

Our team specializes in medical information response writing, with decades of combined experience developing both standard and custom content for day-to-day inquiry management across a variety of therapeutic areas.

Read Less
Compliance

Consistency Across Responses

We help ensure that responses, whether standard or customized, are aligned in structure, tone, and scientific interpretation.

Consistency Across Responses

We help ensure that responses, whether standard or customized, are aligned in structure, tone, and scientific interpretation.

Read Less
Medical writing icon

Practical, Usable Content

Navigable documents are developed with end-use in mind, supporting efficient response handling by medical information teams.

Practical, Usable Content

Navigable documents are developed with end-use in mind, supporting efficient response handling by medical information teams.

Read Less
Connection

Scalable Support for Changing Demand

Support can be adjusted based on inquiry volume, product lifecycle stage, or internal capacity constraints.

Scalable Support for Changing Demand

Support can be adjusted based on inquiry volume, product lifecycle stage, or internal capacity constraints.

Read Less
Clinical Research Solutions icon

Alignment with Internal Workflows

We integrate with existing review processes and systems, supporting established medical, legal, and regulatory workflows without adding unnecessary complexity.

Alignment with Internal Workflows

We integrate with existing review processes and systems, supporting established medical, legal, and regulatory workflows without adding unnecessary complexity.

Read Less
Around the world icon

Global Team

We have writers across multiple geographic regions who can develop global medical information responses or address country-specific needs. This includes native-speaking professionals who...

Read More

Global Team

We have writers across multiple geographic regions who can develop global medical information responses or address country-specific needs. This includes native-speaking professionals who can create or translate documents in more than 35 local languages.

Read Less
Innovation icon

Artificial Intelligence (AI) Capabilities

Our team has experience working with AI tools to help draft scientifically balanced documents. We are also launching an AI tool that is specifically designed...

Read More

Artificial Intelligence (AI) Capabilities

Our team has experience working with AI tools to help draft scientifically balanced documents. We are also launching an AI tool that is specifically designed for medical information writing.

Read Less

Frequently Asked Questions

What regions do you support?

We support medical information writing needs across the Americas, Europe, APAC, and Japan, taking into account regional requirements and variations in response content where applicable.

Do you have experience within my therapeutic area?

We have worked in multiple therapeutic areas, including hematology/oncology, infectious diseases, endocrinology, gastroenterology, neurology, orphan/rare diseases, immunology, and metabolic disorders. We have experience with a variety of product types, including biologics, CAR-T therapies, and medical devices.

What is your process for creating or updating a document?

We work with each client to align the best approach based on existing processes and priorities. At project initiation, we review scope, templates or style guides, timelines, and any upcoming data or expected updates.

During the project, we manage drafting or revisions, including internal quality checks, source annotation, and incorporation of client feedback. Documents can be uploaded into client systems as needed. Our goal is to integrate with your workflow and deliver content that meets your quality standards within agreed timelines.

Can you tell me more about your AI writing tool?

We use a purpose-built AI tool to support medical information writing. The tool includes literature search functionality using established scientific databases (e.g., PubMed) and can assist in generating both standard and custom response drafts.

All content is reviewed, edited, and approved by a qualified medical information writer. The tool has undergone internal evaluation to ensure alignment. The tool is part of an ongoing process, subject to continuous evaluation as new technologies emerge, and it is used to support efficiency rather than replace scientific oversight.

What types of documents do you typically develop?

We primarily develop standard response documents (SRDs) and custom medical information response documents (CRDs). We also support frequently asked questions (FAQs), core content for response libraries, and updates to existing materials as new data becomes available.

Do you work within our existing templates and systems?

Yes. We typically work within client-provided templates, style guides, and document management systems. If needed, we can also help create and/or refine templates to improve clarity and consistency across documents. Our team has experience with a variety of document management systems and referencing applications.

How do you ensure consistency across documents?

We apply structured writing approaches, standardized formatting, and consistent referencing practices. When supporting broader programs, we also consider alignment across documents to maintain consistency in messaging, tone, and scientific interpretation.

Can you support both ongoing work and one-time projects?

Yes. We provide support for both discrete projects (e.g., development of a set of SRDs) and ongoing engagement models that include continuous content development and maintenance.

How do you handle urgent or complex requests?

We can prioritize urgent requests based on agreed timelines and available resources. For complex inquiries, we can conduct a targeted literature review with input from the requestor and develop tailored responses that are reviewed internally before delivery.

How do you stay current with new data or labeling changes?

We rely on client-provided updates and agreed processes to identify when documents require revision. We can also support periodic review cycles to ensure content remains current.

What is the typical turnaround time for documents?

Timelines vary depending on document complexity, scope, and review requirements. At project initiation, we work with you to define realistic and achievable timelines based on your needs.

What level of involvement is required from our team?

The level of involvement can be tailored. Some clients prefer close collaboration during drafting, while others rely on us for initial development with review checkpoints. We adapt to the level of engagement that best fits your team’s capacity and preferences.

Gradient Image

Medical Information Writing Services

Contact us today to discuss how ProPharma's Medical Information Writing Services can help.

News & Insights

First Joint Clinical Assessments (JCAs): Key Lessons for EU HTA

July 14, 2026

First Joint Clinical Assessments (JCAs): Key Lessons for EU HTA

Learn what the first EU Joint Clinical Assessments reveal about evidence planning, PICO strategy, and HTA readiness for successful market access.

Turning Regulatory Complexity into Predictable Study Start-Up Execution

July 13, 2026

Turning Regulatory Complexity into Predictable Study Start-Up Execution

Explore how organizations can navigate regulatory complexity in clinical trials to achieve predictable study start-up timelines and operational excellence.

Regulatory Readiness as a Strategic Advantage in European Study Start-Up

July 6, 2026

Regulatory Readiness as a Strategic Advantage in European Study Start-Up

Discover how regulatory readiness has evolved into a strategic advantage for clinical study start-ups in Europe, impacting timelines and operational efficiency.

ProPharma Advances Technology Enablement Strategy with AI-Assisted Capability for ANDA Submission Development

July 8, 2026

ProPharma Advances Technology Enablement Strategy with AI-Assisted Capability fo...

ProPharma unveils an AI-assisted capability to enhance ANDA submission development, improving efficiency and maintaining regulatory excellence for clients.

ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and HTA Capabilities

June 18, 2026

ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and H...

ProPharma welcomes Kevin van Dooren as Vice President, HEOR and Market Access, strengthening integrated EU regulatory, HTA, reimbursement, and market access capabilities for life sciences companies.

ProPharma Appoints Adrian Pencak as Chief Commercial Officer

May 27, 2026

ProPharma Appoints Adrian Pencak as Chief Commercial Officer

ProPharma announces Adrian Pencak as Chief Commercial Officer, bringing 25 years of leadership experience to enhance global commercial capabilities and client partnerships.

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Case Study Ensuring Continuity of Neonatal Vitamin Prophylaxis During a Product Shortage: A Regulatory and Pharmacovigilance-Led Solution - ProPharma

July 15, 2026

Ensuring Continuity of Neonatal Vitamin Prophylaxis During a Product Shortage: A...

Product shortages involving essential medicines can create significant clinical and regulatory challenges, particularly when vulnerable patient populations depend on uninterrupted access to...

Case Study Meeting Patients Where They Are: Delivering Global Clinical Support for Time-Sensitive Research - ProPharma

June 17, 2026

Meeting Patients Where They Are: Delivering Global Clinical Support for Time-Sen...

Conducting clinical research for rare pediatric populations presents unique operational challenges, particularly when eligible patients may be born anywhere in the world and require immediate...

Case Study Accelerating Commercial Readiness for a Novel Cell Therapy Program - ProPharma

June 10, 2026

Accelerating Commercial Readiness for a Novel Cell Therapy Program

As advanced therapy developers move from research-stage operations toward commercialization, they often face significant challenges in scaling quality systems, aligning regulatory strategy, and...

Tech Meets Touch: Evaluating Empathy and AI in Medical Information Delivery

June 4, 2026

Tech Meets Touch: Evaluating Empathy and AI in Medical Information Delivery

Artificial intelligence (AI) is a hot topic in Medical Information (MI), yet real-world evidence of its impact in regulated, human-led MI environments remains limited. Hear practical, evidence-based...

Foundations of a Compliant EU–UK GMP–GDP Supply Chain: From Importation to Distribution

June 2, 2026

Foundations of a Compliant EU–UK GMP–GDP Supply Chain: From Importation to Distribution

A compliant and efficient EU–UK GMP–GDP supply chain requires a clear understanding of roles, responsibilities, and operational integration across importation, certification, and distribution...

Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market

April 23, 2026

Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market

As cell and gene therapies transition from clinical development to commercialization, organizations face evolving regulatory expectations, expanded CMC requirements, and increased MAH...

News & Insights

First Joint Clinical Assessments (JCAs): Key Lessons for EU HTA

July 14, 2026

First Joint Clinical Assessments (JCAs): Key Lessons for EU HTA

Learn what the first EU Joint Clinical Assessments reveal about evidence planning, PICO strategy, and HTA readiness for successful market access.

Turning Regulatory Complexity into Predictable Study Start-Up Execution

July 13, 2026

Turning Regulatory Complexity into Predictable Study Start-Up Execution

Explore how organizations can navigate regulatory complexity in clinical trials to achieve predictable study start-up timelines and operational excellence.

Regulatory Readiness as a Strategic Advantage in European Study Start-Up

July 6, 2026

Regulatory Readiness as a Strategic Advantage in European Study Start-Up

Discover how regulatory readiness has evolved into a strategic advantage for clinical study start-ups in Europe, impacting timelines and operational efficiency.

Previous Post Arrow Next Post Arrow
ProPharma Advances Technology Enablement Strategy with AI-Assisted Capability for ANDA Submission Development

July 8, 2026

ProPharma Advances Technology Enablement Strategy with AI-Assisted Capability fo...

ProPharma unveils an AI-assisted capability to enhance ANDA submission development, improving efficiency and maintaining regulatory excellence for clients.

ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and HTA Capabilities

June 18, 2026

ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and H...

ProPharma welcomes Kevin van Dooren as Vice President, HEOR and Market Access, strengthening integrated EU regulatory, HTA, reimbursement, and market access capabilities for life sciences companies.

ProPharma Appoints Adrian Pencak as Chief Commercial Officer

May 27, 2026

ProPharma Appoints Adrian Pencak as Chief Commercial Officer

ProPharma announces Adrian Pencak as Chief Commercial Officer, bringing 25 years of leadership experience to enhance global commercial capabilities and client partnerships.

Previous Post Arrow Next Post Arrow
ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Previous Award Arrow Next Award Arrow
Case Study Ensuring Continuity of Neonatal Vitamin Prophylaxis During a Product Shortage: A Regulatory and Pharmacovigilance-Led Solution - ProPharma

July 15, 2026

Ensuring Continuity of Neonatal Vitamin Prophylaxis During a Product Shortage: A...

Product shortages involving essential medicines can create significant clinical and regulatory challenges, particularly when vulnerable patient populations depend on uninterrupted access to...

Case Study Meeting Patients Where They Are: Delivering Global Clinical Support for Time-Sensitive Research - ProPharma

June 17, 2026

Meeting Patients Where They Are: Delivering Global Clinical Support for Time-Sen...

Conducting clinical research for rare pediatric populations presents unique operational challenges, particularly when eligible patients may be born anywhere in the world and require immediate...

Case Study Accelerating Commercial Readiness for a Novel Cell Therapy Program - ProPharma

June 10, 2026

Accelerating Commercial Readiness for a Novel Cell Therapy Program

As advanced therapy developers move from research-stage operations toward commercialization, they often face significant challenges in scaling quality systems, aligning regulatory strategy, and...

Previous Resource Arrow Next Resource Arrow
Tech Meets Touch: Evaluating Empathy and AI in Medical Information Delivery

June 4, 2026

Tech Meets Touch: Evaluating Empathy and AI in Medical Information Delivery

Artificial intelligence (AI) is a hot topic in Medical Information (MI), yet real-world evidence of its impact in regulated, human-led MI environments remains limited. Hear practical, evidence-based...

Foundations of a Compliant EU–UK GMP–GDP Supply Chain: From Importation to Distribution

June 2, 2026

Foundations of a Compliant EU–UK GMP–GDP Supply Chain: From Importation to Distribution

A compliant and efficient EU–UK GMP–GDP supply chain requires a clear understanding of roles, responsibilities, and operational integration across importation, certification, and distribution...

Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market

April 23, 2026

Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market

As cell and gene therapies transition from clinical development to commercialization, organizations face evolving regulatory expectations, expanded CMC requirements, and increased MAH...

Previous Webinar Arrow Next Webinar Arrow